Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease May 9, 2023
TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting May 3, 2023
Longwood Fund Closes $180 Million Fund to Create and Invest in Early-Stage Biotechnology Companies May 3, 2023
Werewolf Therapeutics Publishes Preclinical Data on mWTX-330, an IL-12 INDUKINE™ Molecule, in Cancer Immunology Research April 20, 2023
Lassen Therapeutics Presents Data Demonstrating Anti-IL18 Binding Protein Antibody Efficacy and Enhancement of Anti-Tumor Immunity April 18, 2023
Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder April 6, 2023
